Please confirm you are human

This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.

A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.

Hold with a pointer, or hold Space or Enter.

News

TradingView
tradingview.com > symbols > HAM-116 > financials-statistics-and-ratios > enterprise-value-ebit-fwd

Enterprise value to EBIT forward of Energous Corp. – HAM:116 – TradingView

15+ hour, 47+ min ago   (19+ words) Enterprise value to EBIT forward of Energous Corp. – HAM:116 TradingView Enterprise value to EBIT forward of Energous Corp....

TradingView
tradingview.com > news > reuters.com,2026-09-14:newsml_XB0M5MMM9:0-table-umenohana-group-q1-group-results

TABLE-Umenohana Group -Q1 group results

5+ hour, 49+ min ago   (11+ words) TradingView TABLE-Umenohana Group -Q1 group results...

TradingView
tradingview.com > symbols > BCS-CFI_BLMVAE0 > financials-statistics-and-ratios > price-earnings

Price to earnings ratio of Bci Asset Man Adm Cuota De Fondo De Inversion – BCS:CFI_BLMVAE0 – TradingView

12+ hour, 54+ min ago   (41+ words) Price to earnings ratio of Bci Asset Man Adm Cuota De Fondo De Inversion – BCS:CFI_BLMVAE0 TradingView Bci Asset Man Adm Cuota De Fondo De Inversion Price to earnings ratio of Bci Asset Man Adm Cuota De Fondo De Inversion...

TradingView
tradingview.com > symbols > HAM-116 > financials-statistics-and-ratios

Energous Corp. Statistics – HAM:116 – TradingView

19+ hour, 16+ min ago   (87+ words) Energous Corp. engages in the development of wireless charging technology. It focuses on the product, WattUp, a wireless power technology consisting of proprietary semiconductor chipsets, software controls, hardware designs, and antennas, that enables radio frequency based charging for electronic devices....

TradingView
tradingview.com > news > reuters.com,2026-09-11:newsml_XB1O883S9:0-table-intloop-2025-26-group-results

TABLE-Intloop -2025/26 group results

3+ day, 7+ hour ago   (11+ words) TradingView TABLE-Intloop -2025/26 group results...

TradingView
tradingview.com > news > te_news:582953:0-stocks-in-china-hit-6-week-low

Stocks in China Hit 6-week Low

3+ day, 8+ hour ago   (46+ words) TradingView Stocks in China Hit 6-week Low CSI 300 decreased to 4513.00 Index Points, the lowest since July 2026. Over the past 4 weeks, Shanghai Shenzhen CSI 300 Index lost 3.19%, and in the last 12 months, it decreased 0.73%....

TradingView
tradingview.com > news > te_news:582956:0-stocks-in-china-hit-7-week-low

Stocks in China Hit 7-week Low

3+ day, 8+ hour ago   (43+ words) TradingView Stocks in China Hit 7-week Low SHANGHAI 50 decreased to 2857.00 Index Points, the lowest since July 2026. Over the past 4 weeks, Shanghai 50 lost 2.31%, and in the last 12 months, it decreased 4.05%....

TradingView
tradingview.com > news > tradingview:c4b6f0d5332cb:0-pluri-inc-fy-2026-revenue-1-02m-eps-2-44-10-k-summary

Pluri Inc. FY 2026: Revenue $1.02M, EPS $(2.44) — 10-K Summary

3+ day, 12+ hour ago   (181+ words) TradingView Pluri Inc. reported a fiscal 2026 net loss as revenue fell to $1.02M and losses widened slightly year over year, while loss per share improved due to a higher share count and other factors. - Revenue was $1.02M, compared with $1.34M in the prior…...

TradingView
tradingview.com > news > urn:summary_document_transcript:quartr.com:4152246:0-tnxp-strong-sales-growth-pipeline-progress-and-robust-cash-position-drive-optimism-for-future-milestones

TNXP: Strong sales growth, pipeline progress, and robust cash position drive optimism for future milestones

3+ day, 12+ hour ago   (79+ words) tradingview.com TONMYA's launch for fibromyalgia has shown strong early sales growth and broadening access, with a unique mechanism and favorable tolerability. The pipeline includes a phase II-ready Lyme disease antibody and an anti-CD40 ligand program for transplantation, supported by…...

TradingView
tradingview.com > news > tradingview:4ba60f99f74aa:0-labcorp-outlines-2026-guidance-2026-2029-outlook-with-5-8-revenue-cagr-and-18-10-18-55-adjusted-eps-guidance

Labcorp outlines 2026 guidance, 2026–2029 outlook with 5–8% revenue CAGR and $18.10–$18.55 adjusted EPS guidance

3+ day, 12+ hour ago   (157+ words) TradingView Labcorp outlines 2026 guidance, 2026–2029 outlook with 5–8% revenue CAGR and $18.10–$18.55 adjusted EPS guidance Labcorp reaffirmed 2026 guidance and presented a 2026–2029 long-term outlook targeting 5%–8% revenue CAGR and 8.5%–11.5% adjusted EPS CAGR. - Reaffirms full-year 2026 guidance: enterprise revenue $14,710M–$14,827M and adjusted EPS $18.10–$18.55. - Long-term outlook (2026–2029): revenue CAGR 5%–8% and…...